First National Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.5M Sell
129,056
-1,630
-1% -$380K 1.07% 21
2025
Q4
$27M Sell
130,686
-5,212
-4% -$1.03M 0.9% 24
2025
Q3
$25.2M Sell
135,898
-3,743
-3% -$641K 0.86% 24
2025
Q2
$21.3M Sell
139,641
-2,017
-1% -$310K 0.8% 26
2025
Q1
$23.5M Sell
141,658
-9,322
-6% -$1.46M 0.95% 25
2024
Q4
$21.8M Buy
150,980
+511
+0.3% +$79.2K 0.82% 28
2024
Q3
$24.4M Sell
150,469
-2,624
-2% -$418K 0.94% 25
2024
Q2
$22.4M Buy
153,093
+1,267
+0.8% +$188K 0.92% 23
2024
Q1
$24M Sell
151,826
-9,118
-6% -$1.45M 0.98% 23
2023
Q4
$25.2M Sell
160,944
-17,994
-10% -$2.76M 1.11% 17
2023
Q3
$27.9M Sell
178,938
-1,965
-1% -$324K 1.33% 14
2023
Q2
$29.9M Buy
180,903
+4,777
+3% +$771K 1.39% 12
2023
Q1
$27.3M Sell
176,126
-374
-0.2% -$60.4K 1.45% 13
2022
Q4
$31.2M Buy
176,500
+2,999
+2% +$518K 1.65% 12
2022
Q3
$28.3M Buy
173,501
+5,955
+4% +$1.01M 1.65% 11
2022
Q2
$29.7M Buy
167,546
+25,022
+18% +$4.46M 1.67% 11
2022
Q1
$25.3M Buy
142,524
+5,536
+4% +$942K 1.31% 12
2021
Q4
$23.4M Buy
136,988
+3,426
+3% +$561K 1.23% 13
2021
Q3
$21.6M Sell
133,562
-238
-0.2% -$40.6K 1.29% 13
2021
Q2
$22M Sell
133,800
-5,324
-4% -$881K 1.34% 12
2021
Q1
$22.9M Sell
139,124
-28,104
-17% -$4.55M 1.5% 9
2020
Q4
$26.3M Buy
167,228
+1,155
+0.7% +$170K 1.82% 8
2020
Q3
$24.7M Buy
166,073
+10,596
+7% +$1.57M 1.92% 8
2020
Q2
$21.9M Buy
155,477
+5,276
+4% +$769K 1.85% 7
2020
Q1
$19.7M Buy
150,201
+5,271
+4% +$748K 1.97% 7
2019
Q4
$21.1M Buy
144,930
+3,752
+3% +$509K 1.72% 8
2019
Q3
$18.3M Buy
141,178
+2,832
+2% +$373K 1.64% 11
2019
Q2
$19.3M Buy
138,346
+494
+0.4% +$68.4K 1.8% 7
2019
Q1
$19.3M Buy
137,852
+2,026
+1% +$271K 1.93% 6
2018
Q4
$17.5M Buy
135,826
+6,245
+5% +$871K 1.95% 6
2018
Q3
$17.9M Buy
129,581
+3,241
+3% +$431K 1.82% 6
2018
Q2
$15.3M Buy
126,340
+3,012
+2% +$376K 1.69% 10
2018
Q1
$15.8M Buy
123,328
+1,168
+1% +$158K 1.8% 8
2017
Q4
$17.1M Buy
122,160
+1,184
+1% +$165K 1.88% 6
2017
Q3
$15.7M Buy
120,976
+2,024
+2% +$268K 1.82% 7
2017
Q2
$15.7M Buy
118,952
+4,655
+4% +$594K 1.92% 7
2017
Q1
$14.2M Buy
114,297
+708
+0.6% +$84.6K 1.85% 8
2016
Q4
$13.1M Sell
113,589
-1,350
-1% -$156K 1.84% 9
2016
Q3
$13.6M Buy
114,939
+241
+0.2% +$29.2K 2.04% 7
2016
Q2
$13.9M Buy
114,698
+1,419
+1% +$161K 2.14% 5
2016
Q1
$12.3M Buy
113,279
+1,202
+1% +$124K 1.88% 8
2015
Q4
$11.5M Buy
112,077
+1,702
+2% +$171K 1.82% 7
2015
Q3
$10.3M Buy
110,375
+3,103
+3% +$300K 1.77% 7
2015
Q2
$10.5M Buy
107,272
+3,189
+3% +$319K 1.68% 7
2015
Q1
$10.5M Buy
104,083
+9,197
+10% +$935K 1.79% 5
2014
Q4
$9.92M Buy
94,886
+1,915
+2% +$202K 1.77% 6
2014
Q3
$9.91M Buy
92,971
+1,454
+2% +$151K 1.87% 5
2014
Q2
$9.57M Buy
91,517
+2,897
+3% +$293K 1.85% 4
2014
Q1
$8.71M Buy
88,620
+1,789
+2% +$166K 1.56% 7
2013
Q4
$7.95M Buy
86,831
+230
+0.3% +$21.2K 1.45% 9
2013
Q3
$7.51M Buy
86,601
+1,088
+1% +$97.6K 1.47% 10
2013
Q2
$7.34M Buy
+85,513
New +$7.26M 1.51% 10

Other funds holding JNJ

First National Trust's JNJ Position: Q1 2026 in Review

First National Trust reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $380K and leaving 129,056 shares worth $31.5M. The position accounts for 1.07% of the portfolio, ranked #21.

First National Trust first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • First National Trust held 129,056 shares of Johnson & Johnson worth $31.5M as of Q1 2026.
  • First National Trust sold 1,630 Johnson & Johnson shares in Q1 2026, an estimated $380K.
  • Johnson & Johnson made up 1.07% of First National Trust's portfolio in Q1 2026, its #21 holding.
  • First National Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.